Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Packman

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1980
Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cellsS I Rosenfeld, C H Packman, D E Jenkins, et al.
Blood|October 15, 1993
Signal pathway regulation of interleukin-8-induced actin polymerization in neutrophilsR L Sham, P D Phatak, T P Ihne, et al.
Bone Marrow Transplantation|February 8, 2005
Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantationP B Lockhart, M T Brennan, M L Kent, et al.
Cancer Research|November 1, 1993
The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modifiedS M Freeman, C N Abboud, K A Whartenby, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1987
Aberrant immunoglobulin and c-myc gene rearrangements in patients with nonmalignant monoclonal cryoglobulinemiaA Perl, N Wang, J M Williams, et al.
American Journal of Hematology|May 20, 1998
Treatment of multifocal lymphoma of bone with intensified ProMACE-CytaBOM chemotherapy and involved field radiotherapyA P Rapoport, L S Constine, C H Packman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcomeA P Rapoport, J M Rowe, P A Kouides, et al.
Bone Marrow Transplantation|April 1, 1995
Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 yearsA P Rapoport, J F DiPersio, B A Martin, et al.
Bone Marrow Transplantation|December 1, 1999
Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimexJ M Rowe, A P Rapoport, D H Ryan, et al.
Bone Marrow Transplantation|August 28, 1998
Autotransplantation for relapsed or refractory Hodgkin's disease: long-term follow-up and analysis of prognostic factorsJ E Lancet, A P Rapoport, R Brasacchio, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1980
Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cellsS I Rosenfeld, C H Packman, D E Jenkins, et al.
Blood|October 15, 1993
Signal pathway regulation of interleukin-8-induced actin polymerization in neutrophilsR L Sham, P D Phatak, T P Ihne, et al.
Bone Marrow Transplantation|February 8, 2005
Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantationP B Lockhart, M T Brennan, M L Kent, et al.
Cancer Research|November 1, 1993
The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modifiedS M Freeman, C N Abboud, K A Whartenby, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1987
Aberrant immunoglobulin and c-myc gene rearrangements in patients with nonmalignant monoclonal cryoglobulinemiaA Perl, N Wang, J M Williams, et al.
American Journal of Hematology|May 20, 1998
Treatment of multifocal lymphoma of bone with intensified ProMACE-CytaBOM chemotherapy and involved field radiotherapyA P Rapoport, L S Constine, C H Packman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcomeA P Rapoport, J M Rowe, P A Kouides, et al.
Bone Marrow Transplantation|April 1, 1995
Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 yearsA P Rapoport, J F DiPersio, B A Martin, et al.
Bone Marrow Transplantation|December 1, 1999
Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimexJ M Rowe, A P Rapoport, D H Ryan, et al.
Bone Marrow Transplantation|August 28, 1998
Autotransplantation for relapsed or refractory Hodgkin's disease: long-term follow-up and analysis of prognostic factorsJ E Lancet, A P Rapoport, R Brasacchio, et al.
Pageof 5